Cardio3 diversifies with novel heart access technology platform
This article was originally published in Clinica
Executive Summary
Cardio3 BioSciences (C3BS) is expanding its focus beyond regenerative medicine with the acquisition of CorQuest Medical, a US company developing a technology that allows surgeons to access the heart more quickly and directly to carry out structural heart surgery.